Brief: China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao
March 17 (Reuters) - Dong-E-E-Jiao Co Ltd 000423.SZ: FY REVENUE RMB5.92 BILLION FOR DONG-E-E-JIAO FY NET PROFIT ATTRIBUTABLE FOR DONG-E-E-JIAO RMB1.56 BILLION PROPOSED CASH DIVIDEND OF RMB12.70 FOR EVERY 10 SHARES TO ALL SHAREHOLDERS OF DONG-E-E-JIAO Further company coverage: 000423.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million